New aspects of mineralocorticoid hypertension
- PMID: 2151775
- DOI: 10.1159/000181820
New aspects of mineralocorticoid hypertension
Abstract
Primary aldosteronism is the principal disorder of the zona glomerulosa, and a number of subsets have been identified: unilateral adenoma, bilateral micro- or macronodular hyperplasia (idiopathic aldosteronism), primary hyperplasia, and aldosterone-producing carcinoma, either adrenal or ectopic. The diagnostic criteria for a correct differential diagnosis of these subsets are now quite reliable, and our experience is presented in detail. Unfortunately, the pathogenesis of most of these forms is still poorly recognized and requires further investigation. An extreme sensitivity to angiotensin II is present in patients with idiopathic aldosteronism, and a role of adrenal renin is now being advocated. A peculiar form of hyperaldosteronism is the glucocorticoid-remediable subtype. An unusual sensitivity of aldosterone to ACTH is present in this form. The qualitative biochemical abnormality in this disorder consists of a marked overproduction of products of the cortisol C-18-oxidation pathway, 18-hydroxycortisol and 18-oxocortisol, which are more abundant than aldosterone and 18-hydroxycorticosterone. A family with 3 affected sibs has been studied by our group. In other clinical situations, classical zona fasciculata mineralocorticoids (deoxycorticosterone [DOC], corticosterone, and their 18-hydroxy compounds) are secreted in excess. The hypertensive diseases of this zone are rare DOC-secreting tumors and two forms of congenital adrenal hyperplasia, the 11 beta-hydroxylase and 17 alpha-hydroxylase deficiency syndromes, which are identified by the presence of hypokalemia and suppressed renin activity. DOC is the only mineralocorticoid hormone (MCH) oversecreted in the 11-hydroxylase deficiency syndromes, while all ACTH-dependent MCH levels are very high in the 17-hydroxylase deficiency syndromes.(ABSTRACT TRUNCATED AT 250 WORDS)
Similar articles
-
Steroids and hypertension.J Steroid Biochem Mol Biol. 1991;40(1-3):35-44. doi: 10.1016/0960-0760(91)90165-2. J Steroid Biochem Mol Biol. 1991. PMID: 1958539 Review.
-
Investigating mineralocorticoid hypertension.J Hypertens Suppl. 2003 May;21(2):S25-30. doi: 10.1097/00004872-200305002-00005. J Hypertens Suppl. 2003. PMID: 12929904 Review.
-
Steroid characteristics of mineralocorticoid adrenocortical hypertension.Clin Chem. 1991 Oct;37(10 Pt 2):1843-8. Clin Chem. 1991. PMID: 1914200 Review.
-
The mineralocorticoid hormone pathways in hypertension with hyperaldosteronism.Clin Exp Hypertens A. 1982;4(9-10):1677-83. doi: 10.3109/10641968209061633. Clin Exp Hypertens A. 1982. PMID: 7139973
-
[Primary hyperaldosteronism].Minerva Endocrinol. 1995 Mar;20(1):49-54. Minerva Endocrinol. 1995. PMID: 7651282 Review. Italian.
Cited by
-
[Mineralocorticoid-induced hypertension].Med Klin (Munich). 1997 May 15;92(5):273-8. doi: 10.1007/BF03045082. Med Klin (Munich). 1997. PMID: 9244833 Review. German.
-
In vitro glucocorticosteroid and mineralocorticosteroid biosynthesis in Conn's adenoma tissues.J Endocrinol Invest. 1993 Jan;16(1):65-8. doi: 10.1007/BF03345834. J Endocrinol Invest. 1993. PMID: 8445158
-
Hormonal characteristics of primary aldosteronism due to unilateral adrenal hyperplasia.J Endocrinol Invest. 1998 Sep;21(8):531-6. doi: 10.1007/BF03347340. J Endocrinol Invest. 1998. PMID: 9801995
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical